ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SABCS: Roche's Perjeta builds case as HER2-positive add-on
December 12, 2019Roche is in the hot seat as its longtime breast cancer blockbuster Herceptin faces a growing stable of biosimilar challengers. But other drugs in Roche's portfolio are on the rise. -
Roche's Kadcyla beats Herceptin breast cancer disease recurrence and death risk
October 19, 2018Roche has unveiled new data for its antibody-drug conjugate Kadcyla (trastuzumab emtansine) in the treatment of patients with HER2-positive early breast cancer (eBC) who...
Pharma Sources Insight January 2025
